Nautilus Biotechnolgy logo

Nautilus Biotechnolgy

NAUT | NASDAQ
Chart Builder DCF Calculator
$2.10
-$0.22 (-9.48%)
At close: Nov 16, 2026, 4:00 PM ET
$2.13
+$0.03 (+1.37%)
After-hours: Nov 16, 2026, 7:54 PM ET
-9.48%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
42.2
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #467/1021 (Top 46%)

Key Statistics

Market Data

Market Cap $267.48M
1D Range
2.10 2.31
52W Range
0.85 3.95

Valuation (TTM)

PE -4.57
PB 2.29
EV/EBITDA -3.83

Valuation (NTM)

Forward PE N/A
Forward PEG 0.66
Price Target $3.50
Loading financial charts...

Profile

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. Th...

Sector Healthcare
Industry Biotechnology
Employees 128
IPO Date Aug 7, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Oct 27, 2026
EPS
-$0.12
Beat +14.29%
REV
$234K
Beat +13.45%
Next Earnings
Feb 25, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$3.50
Upside
+66.67%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.